111 related articles for article (PubMed ID: 11518356)
1. Activities of plasminogen activator, plasmin and kallikrein in synovial fluid from patients with temporomandibular joint disorders.
Sakamaki H; Ogura N; Kujiraoka H; Akiba M; Abiko Y; Nagura H
Int J Oral Maxillofac Surg; 2001 Aug; 30(4):323-8. PubMed ID: 11518356
[TBL] [Abstract][Full Text] [Related]
2. Aggrecanase analysis of synovial fluid of temporomandibular joint disorders.
Yoshida K; Takatsuka S; Tanaka A; Hatada E; Nakamura H; Nakagawa K; Okada Y
Oral Dis; 2005 Sep; 11(5):299-302. PubMed ID: 16120116
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint.
Mizui T; Ishimaru J; Miyamoto K; Kurita K
Br J Oral Maxillofac Surg; 2001 Aug; 39(4):310-4. PubMed ID: 11437431
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders.
Yoshida K; Takatsuka S; Hatada E; Nakamura H; Tanaka A; Ueki K; Nakagawa K; Okada Y; Yamamoto E; Fukuda R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):22-7. PubMed ID: 16831668
[TBL] [Abstract][Full Text] [Related]
5. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha.
Emshoff R; Puffer P; Rudisch A; Gassner R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):442-9. PubMed ID: 11027380
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of cyclooxygenase-1 and -2 in synovial tissues from patients with internal derangement or osteoarthritis of the temporomandibular joint.
Seki H; Fukuda M; Iino M; Takahashi T; Yoshioka N
Int J Oral Maxillofac Surg; 2004 Oct; 33(7):687-92. PubMed ID: 15337183
[TBL] [Abstract][Full Text] [Related]
7. Changes in synovial fluid N-acetyl-beta-glucosaminidase activity in the human temporomandibular joint with dysfunction.
Kamada A; Fujita A; Kakudo K; Okazaki J; Ida M; Sakaki T
J Osaka Dent Univ; 1993 Oct; 27(2):107-11. PubMed ID: 8182502
[TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase activity in synovial fluids in patients with temporomandibular joint internal derangement.
Güven O; Tekin US; Durak I; Keller EE; Hatipoglu M
J Oral Maxillofac Surg; 2007 Oct; 65(10):1940-3. PubMed ID: 17884519
[TBL] [Abstract][Full Text] [Related]
9. Specific expression of inducible nitric oxide synthase in the synovium of the diseased temporomandibular joint.
Takahashi T; Homma H; Nagai H; Seki H; Kondoh T; Yamazaki Y; Fukuda M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):174-81. PubMed ID: 12582357
[TBL] [Abstract][Full Text] [Related]
10. Effects of intra-articular administration of sodium hyaluronate on plasminogen activator system in temporomandibular joints with osteoarthritis.
Tang YL; Zhu GQ; Hu L; Zheng M; Zhang JY; Shi ZD; Liang XH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):541-7. PubMed ID: 20185343
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
13. A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.
Selwyn BM; Figueroa CD; Fink E; Swan A; Dieppe PA; Bhoola KD
Ann Rheum Dis; 1989 Feb; 48(2):128-33. PubMed ID: 2649023
[TBL] [Abstract][Full Text] [Related]
14. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
15. Synovial matrix metalloproteinase-2 in different stages of sheep temporomandibular joint osteoarthrosis.
Miyamoto K; Ishimaru J; Kurita K; Goss AN
J Oral Maxillofac Surg; 2002 Jan; 60(1):66-72. PubMed ID: 11757011
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement.
Tanaka A; Kumagai S; Kawashiri S; Takatsuka S; Nakagawa K; Yamamoto E; Matsumoto N
J Oral Pathol Med; 2001 Jan; 30(1):59-64. PubMed ID: 11140902
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
Saxne T; Lecander I; Geborek P
J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
[TBL] [Abstract][Full Text] [Related]
18. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 in synovial tissue and fluid of dysfunctional temporomandibular joints with internal derangement.
Quinn JH; Kent JH; Moise A; Lukiw WJ
J Oral Maxillofac Surg; 2000 Nov; 58(11):1229-32; discussion 1232-3. PubMed ID: 11078133
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders.
Takahashi T; Kondoh T; Kamei K; Seki H; Fukuda M; Nagai H; Takano H; Yamazaki Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Nov; 82(5):505-9. PubMed ID: 8936513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
